Life
Tortugas Neuroscience Emerges with Ambitious Drug Development Goals
Tortugas Neuroscience has officially launched, aiming to develop new treatments for brain disorders by leveraging licenses from Jiangsu Hansoh and Eisai.
Editorial Staff
1 min read
Updated 17 days ago
On April 21, 2026, Tortugas Neuroscience announced its launch, signaling a new player in the pharmaceutical industry focused on brain disorders and other medical conditions.
The company plans to develop drugs that are licensed from two notable partners: the Chinese drugmaker Jiangsu Hansoh and the Japanese pharmaceutical firm Eisai.
This initiative reflects a growing interest in addressing complex neurological issues through innovative drug development strategies.